Pharmacolog i Uppsala AB Share Price
Equities
PERP B
SE0019071812
Advanced Medical Equipment & Technology
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0998 SEK | +9.91% | +1.22% | +76.33% |
24/04 | Perpetua Medical AB Appoints Camilla Lonn as CFO | CI |
23/04 | Pharmacolog i Uppsala AB will Change its Ticker to PERP B from PHLOG B | CI |
Sales 2022 | 10.11M 926K 77.28M | Sales 2023 | 9.94M 910K 75.92M | Capitalization | 3.75M 343K 28.65M |
---|---|---|---|---|---|
Net income 2022 | -19M -1.74M -145M | Net income 2023 | -18M -1.65M -138M | EV / Sales 2022 | 3.67 x |
Net cash position 2022 | 10.3M 943K 78.74M | Net cash position 2023 | 5.48M 501K 41.85M | EV / Sales 2023 | -0.17 x |
P/E ratio 2022 |
-2.09
x | P/E ratio 2023 |
-0.13
x | Employees | 10 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 49.1% |
1 day | +9.91% | ||
1 week | +1.22% | ||
Current month | -3.57% | ||
1 month | -8.86% | ||
3 months | +33.78% | ||
6 months | +149.50% | ||
Current year | +76.33% |
Managers | Title | Age | Since |
---|---|---|---|
Hans Erik Dahlin
FOU | Founder | 79 | 15/07/15 |
Lars Gusch
CEO | Chief Executive Officer | 50 | 01/22/01 |
LiseLotte Söder
DFI | Director of Finance/CFO | 60 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 01/17/01 | |
Hans Erik Dahlin
FOU | Founder | 79 | 15/07/15 |
Ragnar Linder
BRD | Director/Board Member | 71 | 01/19/01 |
Date | Price | Change | Volume |
---|---|---|---|
29/24/29 | 0.0998 | +9.91% | 1 274 |
26/24/26 | 0.0908 | -4.42% | 138,200 |
25/24/25 | 0.095 | -4.04% | 892,254 |
24/24/24 | 0.099 | +2.06% | 49,697 |
23/24/23 | 0.097 | -1.62% | 366,694 |
Delayed Quote Nasdaq Stockholm, April 29, 2024 at 02:17 pm IST
More quotes1st Jan change | Capi. | |
---|---|---|
+76.33% | 899K | |
-11.67% | 19.08B | |
-46.21% | 2.65B | |
+18.15% | 1.87B | |
-3.12% | 1.61B | |
+23.86% | 1.21B | |
-10.69% | 1.02B | |
-20.89% | 905M | |
-6.04% | 716M | |
-18.10% | 682M |
- Stock Market
- Equities
- PERP B Stock